4.6 Article

Validation of the Antioxidant and Enzyme Inhibitory Potential of Selected Triterpenes Using In Vitro and In Silico Studies, and the Evaluation of Their ADMET Properties

Journal

MOLECULES
Volume 26, Issue 21, Pages -

Publisher

MDPI
DOI: 10.3390/molecules26216331

Keywords

antioxidants; enzyme inhibition; in vitro assays; triterpenes; virtual screening; inflammation; Alzheimer's disease

Funding

  1. King Saud University Researchers Supporting Project [RSP-2021/294]
  2. King Saud University, Riyadh, Saudi Arabia

Ask authors/readers for more resources

The antioxidant and enzyme inhibitory potential of fifteen cycloartane-type triterpenes were investigated, revealing high activities in certain compounds that indicate potential pharmacological value.
The antioxidant and enzyme inhibitory potential of fifteen cycloartane-type triterpenes' potentials were investigated using different assays. In the phosphomolybdenum method, cycloalpioside D (6) (4.05 mmol TEs/g) showed the highest activity. In 1,1-diphenyl-2-picrylhydrazyl (DPPH*) radical and 2,2 '-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS) cation radical scavenging assays, cycloorbicoside A-7-monoacetate (2) (5.03 mg TE/g) and cycloorbicoside B (10) (10.60 mg TE/g) displayed the highest activities, respectively. Oleanolic acid (14) (51.45 mg TE/g) and 3-O-beta-d-xylopyranoside-(23R,24S)-16 beta,23;16 alpha,24-diepoxycycloart-25(26)-en-3 beta,7 beta-diol 7-monoacetate (4) (13.25 mg TE/g) revealed the highest reducing power in cupric ion-reducing activity (CUPRAC) and ferric-reducing antioxidant power (FRAP) assays, respectively. In metal-chelating activity on ferrous ions, compound 2 displayed the highest activity estimated by 41.00 mg EDTAE/g (EDTA equivalents/g). The tested triterpenes showed promising AChE and BChE inhibitory potential with 3-O-beta-d-xylopyranoside-(23R,24S)-16 beta,23;16 alpha,24-diepoxycycloart-25(26)-en-3 beta,7 beta-diol 2 ',3 ',4 ',7-tetraacetate (3), exhibiting the highest inhibitory activity as estimated from 5.64 and 5.19 mg GALAE/g (galantamine equivalent/g), respectively. Compound 2 displayed the most potent tyrosinase inhibitory activity (113.24 mg KAE/g (mg kojic acid equivalent/g)). Regarding alpha-amylase and alpha-glucosidase inhibition, 3-O-beta-d-xylopyranoside-(23R,24S)-16 beta,23;16 alpha,24-diepoxycycloart-25(26)-en-3 beta,7 beta-diol (5) (0.55 mmol ACAE/g) and compound 3 (25.18 mmol ACAE/g) exerted the highest activities, respectively. In silico studies focused on compounds 2, 6, and 7 as inhibitors of tyrosinase revealed that compound 2 displayed a good ranking score (-7.069 kcal/mole) and also that the & UDelta;G free-binding energy was the highest among the three selected compounds. From the ADMET/TOPKAT prediction, it can be concluded that compounds 4 and 5 displayed the best pharmacokinetic and pharmacodynamic behavior, with considerable activity in most of the examined assays.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available